FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management
Dockets Entered On December 13, 2004
Docket # Title
1978P-0225 ESTAB TOLERANCES FOR SODIUM CONTENT OF PROCESSED FOODS
1993V-0376 Laser Light Show
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
1999F-4372 National Fisheries Institute and the Louisiana Dep of Agricu
1999F-5321 Food Safety & Inspection service safe use of ionizing radiai
1999F-5322 Ionizing Radiation for the Treatment of Food
1999F-5522 Ionizing radiation /control of Food-borne pathogens safe use
2000N-0504 Egg Safety Action Plan
2000N-1571 Enrofloxacin for Poultry: Opportunity for Hearing
2001F-0047 Foodborne pathogens in raw-frozen-cooked-partially cooked
2003D-0380 Draft Guidance for Industry: PAT - A Framework for Innovative Pharmaceutical Manufacturing and Quality Assurance; Availability
2003P-0029 Remove metered-dose inhalers (MDI) containing moiety albuter
2003P-0544 Modify existing food additive regulation with respect to the irradiation of ground beef byproducts
2004D-0343 Hospital Bed System Dimensional Guidance to Reduce Entrapment
2004D-0377 International Conference on Harmonisation; Draft Guidance on E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs
2004N-0355 Scientific Considerations Related to Developing Follow-on Protein Products
2004P-0074 oxandrolone and widely used anti-coagulant durgs containing the active drug warfarin
2004P-0202 Notify State & Federal regulators of GRAS requirements of milk protein Concentrate
2004P-0262 Withdraw approval of ANDA suitability petition
1978P-0225 ESTAB TOLERANCES FOR SODIUM CONTENT OF PROCESSED FOODS
ANS 24 HFE-88 Vol #: 1
1993V-0376 Laser Light Show
VRA 6 HFZ-300 to Kozmic Lazer Show, LLP Vol #: 1
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
LET 14957 Weider Nutritiona International Inc. Vol #: 132
LET 14958 Weider Nutrition International Inc. Vol #: 132
LET 14959 Weider Nutrition International Inc, Vol #: 132
LET 14960 Weider Nutrition International Inc. Vol #: 132
LET 14961 Weider Nutrition International Inc. Vol #: 132
LET 14962 Weider Nutrition International Inc. Vol #: 132
LET 14963 Weider Nutrition International Inc. Vol #: 132
LET 14964 Weider Nutrition International Inc. Vol #: 132
LET 14965 Weider Nutrition International Inc. Vol #: 132
LET 14966 Weider Nutrition International Inc. Vol #: 132
LET 14967 Weider Nutrition International Inc. Vol #: 132
LET 14968 Weider Nutrition International Inc. Vol #: 132
LET 14969 Herbalife International of America, Inc. Vol #: 132
LET 14970 Weider Nutrition International Inc. Vol #: 132
LET 14971 Weider Nutrition International Inc. Vol #: 132
LET 14972 Weider Nutrition International Inc. Vol #: 132
LET 14973 Weider Nutrition International Inc. Vol #: 132
LET 14974 Weider Nutrition International Inc. Vol #: 132
LET 14975 Weider Nutrition International Inc. Vol #: 132
LET 14976 Weider Nutritiion International Inc. Vol #: 132
LET 14977 Weider Nutrition International Inc. Vol #: 132
LET 14978 Vital Nutrients Vol #: 132
LET 14979 Source Naturals Vol #: 132
LET 14980 Anabolic Laboratories, Inc. Vol #: 132
1999F-4372 National Fisheries Institute and the Louisiana Dep of Agricu
C 81
Attachment A, B
Public Citizen and Center for Food Safety Vol #: 8
1999F-5321 Food Safety & Inspection service safe use of ionizing radiai
C 79
Attachment A, B
Public Citizen and Center for Food Safety Vol #: 8
1999F-5322 Ionizing Radiation for the Treatment of Food
C 78
Attachment A, B
Public Citizen and Center for Food Safety Vol #: 6
1999F-5522 Ionizing radiation /control of Food-borne pathogens safe use
C 82
Attachment A, B
Public Citizen Citizen and Center for Food Safety Vol #: 6
2000N-0504 Egg Safety Action Plan
C 158 B. Blitz Vol #: 10
C 159 R. RoQue Vol #: 10
C 160 C. Berretta Vol #: 10
C 161 P. Gutman et al Vol #: 10
C 162 Braswell Foods Vol #: 10
C 163 S. Castellanos Vol #: 10
C 164 S. Podell Vol #: 10
C 165 M. Green Vol #: 10
C 166 S. Payne Vol #: 10
C 167 H. Balhiser Vol #: 10
C 168 M and P Max Vol #: 10
C 169 Hidden Villa Ranch Vol #: 19
C 170 Ft. Recovery Equity, Inc. Vol #: 19
C 171 M. O'Donovan Vol #: 19
C 172 L. Sewell Vol #: 19
C 173 Warehouse Shell Sales, Co. Vol #: 19
C 174 T. Varga Vol #: 19
C 175 S. Mahon Vol #: 19
C 176 Baer Brothers, Inc. Vol #: 19
C 177 M and P Max Vol #: 19
C 178 C. Shannon Vol #: 19
C 179 D. Hemmings Vol #: 19
2000N-1571 Enrofloxacin for Poultry: Opportunity for Hearing
EXB 715 Bayer Corporation Vol #: 465
EXB 716 Bayer Corporation Vol #: 465
EXB 717 Bayer Corporation Vol #: 465
EXB 718 Bayer Corporation Vol #: 465
EXB 719 Bayer Corporation Vol #: 465
2001F-0047 Foodborne pathogens in raw-frozen-cooked-partially cooked
C 77
Attachment A, B
Public Citizen and Center for Food Safety Vol #: 8
2003D-0380 Draft Guidance for Industry: PAT - A Framework for Innovative Pharmaceutical Manufacturing and Quality Assurance; Availability
C 16 Animal Health Institute Vol #: 3
2003P-0029 Remove metered-dose inhalers (MDI) containing moiety albuter
C 34 Asthma Therapy Coalition (ATC) Vol #: 6
C 35 Honeywell International, Inc. (Honeywell) Vol #: 6
2003P-0544 Modify existing food additive regulation with respect to the irradiation of ground beef byproducts
C 38
Attachment A, B
Public Citizen and Center for Food Safety Vol #: 2
2004D-0343 Hospital Bed System Dimensional Guidance to Reduce Entrapment
C 12 University of Wisconsin Hospital and Clinics Vol #: 2
2004D-0377 International Conference on Harmonisation; Draft Guidance on E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs
C 4
FR Notice
Boehringer Ingelheim Pharmcaceuticals, Inc. Vol #: 1
C 5
Attachment 1, 2
Merck & Co., INc. Vol #: 1
C 6 Bristol-Myers Squibb Company Vol #: 1
EXT 1 Wyeth Pharmaceuticals (Wyeth) Vol #: 1
2004N-0355 Scientific Considerations Related to Developing Follow-on Protein Products
C 9 Generic Pharmaceutical Assn (GPhA) Vol #: 4
2004P-0074 oxandrolone and widely used anti-coagulant durgs containing the active drug warfarin
C 4 D. Flockhart, M.D., PhD Vol #: 1
2004P-0202 Notify State & Federal regulators of GRAS requirements of milk protein Concentrate
C 11 J. Kinsman Vol #: 1
2004P-0262 Withdraw approval of ANDA suitability petition
LET 1 HFD-005 to King & Spalding LLP Vol #: 1

Page created on December 14, 2004 dp
Page updated on December 27, 2004 jb

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management